Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-10 Sale |
2023-03-10 09:31 am |
Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer |
169,538 | $0 | $0 | 0 (Direct) |
View |
| 2023-01-18 Sale |
2023-01-20 4:34 pm |
Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer |
2,008 | $26.89 | $53,995 | 169,538 (Direct) |
View |
| 2022-10-18 Sale |
2022-10-20 4:54 pm |
Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer |
1,703 | $25.2 | $42,916 | 171,546 (Direct) |
View |
| 2022-07-18 Sale |
2022-07-20 4:37 pm |
Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer |
1,704 | $12.87 | $21,930 | 173,249 (Direct) |
View |
| 2022-04-19 Sale |
2022-04-21 4:25 pm |
Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer |
7,049 | $10.45 | $73,662 | 174,953 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2025-02-28 7:50 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Merendino Lauren Chief Commercial Officer |
0 | $0 | 666,256 (Direct) |
View |
| 2024-03-25 Option Award |
2024-03-28 12:36 pm |
2025-03-25 2034-03-25 |
ESSA Pharma Inc. | EPIX | Merendino Lauren Director |
25,000 | $0 | 25,000 (Direct) |
View |
Ownership |
2023-06-06 4:30 pm |
N/A 2033-06-05 |
ESSA Pharma Inc. | EPIX | Merendino Lauren Director |
0 | $0 | 50,000 (Direct) |
View |
| 2022-04-15 Option Award |
2022-04-19 4:48 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer |
103,703 | $0 | 182,002 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 4:13 pm |
N/A 2031-04-14 |
Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer |
201,599 | $0 | 201,599 (Direct) |
View |
Ownership |
2021-04-08 4:48 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer |
0 | $0 | 0 (Direct) |
View |